At a Glance
- As the number of people with presbyopia continues to increase, so too does the size of this potentially lucrative market
- Corneal inlays are a proven method of presbyopia correction, and a number are commercially available today
- All, however, use synthetic materials, which hold a small risk of biocompatibility issues
- To avoid those issues, allogenic inlays that utilize donor human corneal tissue, which would have otherwise been wasted, are currently under investigation
Refractive surgery is a mostly elective, and therefore relatively lucrative market. As such, there has been a big focus on technological innovation in the field, and the last decade has seen great advances made in laser refractive surgery, clear lens exchange, and phakic IOL design. Thanks to the demographic bulge that is the baby boomer generation, the customer base is only likely to increase, with presbyopes representing the largest potential market for refractive correction. It’s precisely for this indication that corneal inlays have been – and are being – developed.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
If you don’t have an account you can:
REGISTER NOW – it’s FREE and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login as a Guest or via Social Media
This will allow you to read this article but you will only have limited access to The Ophthalmologist.Login as Guest Facebook Google+ LinkedIn Twitter